CVE-2023-31167
No known exploitation. EPSS puts it in the 34th percentile. A vendor fix is available.
What to do
The vendor has published a fix. Version details are below where the sources state them.
What it is
From the CVE record
Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability in Schweitzer Engineering Laboratories SEL-5036 acSELerator Bay Screen Builder Software on Windows allows Relative Path Traversal. SEL acSELerator Bay Screen Builder software is distributed by SEL-5033 SEL acSELerator RTAC, SEL-5030 Quickset, and SEL Compass. CVE-2023-31167 and was patched in the acSELerator Bay Screen Builder release available on 20230602. Please contact SEL for additional details. This issue affects SEL-5036 acSELerator Bay Screen Builder Software: before 1.0.49152.778.
In plain language
No plain-language summary for this CVE yet.
Exploitation
Where each signal puts this CVE on the scale from published to confirmed exploited.
- CISA KEV
Not in the catalog. CISA has not confirmed exploitation.
- Public exploits
No public exploit or proof of concept found in the sources we track.
- EPSS
0.4% chance of exploitation activity in the next 30 days, which ranks it in the 34th percentile of scored CVEs.
Exploit Prediction Scoring System, FIRST.org. A probability, not a confirmation.
Lifecycle
5 events over 448 days, from the signal feeds we watch.
- Patch availablerecord updated
- Publishedweakness classified, att&ck mapped
Affected products
Technical detail
CVSS 3.1 vector
Open in the CVSS calculatorCVSS:3.1/AV:L/AC:L/PR:L/UI:R/S:U/C:N/I:H/A:N
Scored 5.0 by NVD.
How it is reached
- Attack Vector LocalRequires local access to the vulnerable system (e.g. local login, malicious file)
- Attack Complexity LowNo special conditions — the attack can be reliably reproduced
- Privileges Required LowRequires basic user-level privileges
- User Interaction RequiredA user must click a link, open a file, or perform some action
Scope
- Scope UnchangedImpact is limited to the vulnerable component itself
Impact if exploited
- Confidentiality NoneNo confidentiality impact
- Integrity HighTotal loss of integrity — attacker can modify any data in the component
- Availability NoneNo availability impact
Weaknesses
ATT&CK techniques
Mapped from the weaknesses above (CWE to ATT&CK), not observed in attacks.
Sources
References in the record
And 1 more reference. See all after sign-in
Watch the software you run.
My Stack ranks new CVEs for your products by real-world exploitation, so the next serious one reaches you without reading every advisory.
We'll flag the next CVE, public exploit or patch for SEL-5036 AcSELerator…, not every advisory.
A free account adds
- The full version matrix and every affected product
- Exploit links, proofs of concept and Metasploit modules
- Email alerts for the products you watch
- The same data over REST API, MCP and CLI